Daniel Williamson

Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study

Ed C. Schwalbe, Janet C. Lindsey, Sirintra Nakjang et al. · The Lancet Oncology · 2017 · 504 citations · Full text

Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors

Johanna Theruvath, Elena Sotillo, Christopher Mount et al. · Nature Medicine · 2020 · 288 citations · Full text

Cancer Immunosurveillance, Medicine, Immunology +8

Pediatric pan-central nervous system tumor analysis of immune-cell infiltration identifies correlates of antitumor immunity

Yura Grabovska, Alan Mackay, Patricia O’Hare et al. · Nature Communications · 2020 · 225 citations · Full text

Combined MYC and P53 Defects Emerge at Medulloblastoma Relapse and Define Rapidly Progressive, Therapeutically Targetable Disease

Rebecca M. Hill, Sanne Kuijper, Janet C. Lindsey et al. · Cancer Cell · 2014 · 205 citations · Full text

P53-myc Interactions, Malignant Disease, Medicine +12

Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding

Anetta Ptasinska, Salam A. Assi, D Mannari et al. · Leukemia · 2012 · 175 citations · Full text